Allurion Technologies, Inc. (ALUR)

Last Closing Price: 3.02 (2024-02-20)

Company Description

Allurion Technologies Inc. is dedicated to ending obesity. The Allurion Program is a weight loss platform which combines the Allurion Gastric Balloon and only swallowable, procedure-less gastric balloon for weight loss, the Allurion Virtual Care Suite including the Allurion Mobile App for consumers, Allurion Insights for health care providers featuring the Iris AI Platform, and the Allurion Connected Scale and Health Tracker devices. Allurion Technologies Inc., formerly known as Compute Health Acquisition Corp., is based in NATICK, Mass.

Financials, Fundamental Metrics & Ratios
Revenue (Most Recent Fiscal Year) --
Net Income (Most Recent Fiscal Year) $32.37M
PE Ratio (Current Year Earnings Estimate) --
PE Ratio (Trailing 12 Months) --
PEG Ratio (Long Term Growth Estimate) --
Price to Sales Ratio (Trailing 12 Months) --
Price to Book Ratio (Most Recent Quarterly Book Value per Share) --
Price to Cash Ratio (Most Recent Annual Cash Flow per Share) 1.87
Pre-Tax Margin (Trailing 12 Months) --
Net Margin (Trailing 12 Months) --
Return on Equity (Trailing 12 Months) --
Return on Assets (Trailing 12 Months) -16.60%
Current Ratio (Most Recent Fiscal Quarter) 1.30
Quick Ratio (Most Recent Fiscal Quarter) 1.26
Debt to Common Equity (Most Recent Fiscal Quarter) --
Inventory Turnover (Trailing 12 Months) 0.11
Book Value per Share (Most Recent Fiscal Quarter) $-0.38
Earnings per Share (Most Recent Fiscal Quarter) $-0.61
Earnings per Share (Most Recent Fiscal Year) --
Diluted Earnings per Share (Trailing 12 Months) --
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Common Shares Outstanding 47.51M
Free Float 38.01M
Market Capitalization $133.50M
Average Volume (Last 20 Days) 0.03M
Beta (Past 60 Months) 0.03
Percentage Held By Insiders (Latest Annual Proxy Report) 20.00%
Percentage Held By Institutions (Latest 13F Reports) 26.55%
Annual Dividend (Based on Last Quarter) $0.00
Dividend Yield (Based on Last Quarter) 0.00%